Press release

Siemens Healthineers plans change of auditor to PwC 

Published on September 30, 2022
<p></p><ul><li><b>Supervisory Board welcomes Audit Committee’s recommendation to propose PwC to the Annual Shareholders’ Meeting 2024 as auditor for fiscal year 2024</b></li><li><b>A tender procedure in accordance with the legal requirements was carried out</b></li></ul><p></p><p>The Supervisory Board welcomes the Audit Committee’s recommendation to propose PricewaterhouseCoopers GmbH, Wirtschaftsprüfungsgesellschaft, as auditor for fiscal year 2024 (beginning October 1, 2023) to the shareholders at the Annual Shareholders’ Meeting 2024. The decision was preceded by a comprehensive tender process in accordance with current European legal standards.<br><br>“PwC has submitted the most attractive offer in a comprehensive bidding procedure – with a combination of professionalism, specialist and industry knowledge, an impressive track record in taking on new audit mandates, and an extensive approach to digitalization,” said Dr. Marion Helmes, Chair of the Audit Committee of the Supervisory Board of Siemens Healthineers AG. Dr. Jochen Schmitz, Chief Financial Officer (CFO) of Siemens Healthineers AG, added: “I am confident that PwC’s high standards meet our strict requirements for independent auditing.”<br><br>The Supervisory Board intends to submit an election proposal to the Annual Shareholders’ Meeting based on the recommendation of the Audit Committee. On the basis of this election proposal, the Annual Shareholders’ Meeting 2024 of Siemens Healthineers AG will vote on the auditor of the financial statements and consolidated financial statements as well as the auditor for the review of the half-year financial report for fiscal year 2024.<br><br>The audit mandate can then be issued to PwC for fiscal year 2024 and subsequently be extended annually by the Annual Shareholders’ Meeting; in accordance with the currently applicable legal standards, up to and including fiscal year 2033. The audit firm’s partners responsible for carrying out the statutory audit would change on a regular basis within the time limits laid down by law.<br><br>For further information on Siemens Healthineers’ supervisory board and its audit committee, please see <a href="/investor-relations/supervisory-board"></a><br></p>

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at